Your session is about to expire
← Back to Search
Ad/PNP + Fludarabine for Head and Neck Cancer
Study Summary
This trial is testing a repeat dose of a cancer drug combo to see if it's safe and effective against advanced head and neck cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am on blood thinners not just for keeping my veins open.I do not have any uncontrolled diseases like diabetes or high blood pressure.My kidney function is normal, based on creatinine levels or clearance.My cancer in the head or neck area cannot be cured with treatment.I had radiation less than 4 weeks ago and all my measurable cancer areas were treated.I have a history of HIV.My tumor can be measured and is suitable for direct injections, even if I have other tumors that can't be injected.I am 18 years old or older.I haven't taken long-term steroids or immune-weakening drugs in the last 2 weeks.All standard treatments have failed or I can't use them due to side effects.My liver function tests are within normal limits.I haven't had a heart attack, stroke, severe heart failure, liver disease, or unstable chest pain in the last 6 months.I do not have severe nerve pain or damage.I have recovered from major side effects of my previous treatments.I am not pregnant or I am incapable of becoming pregnant due to surgery or menopause.I am currently taking allopurinol.I had chemotherapy less than 4 weeks ago but have recovered from the side effects.I am not pregnant or breastfeeding.I have had a fever over 38.1°C.I can perform all self-care but cannot work.I have received gene therapy or viral therapy for cancer.I have or had leukemia.
- Group 1: Ad/PNP + fludarabine phosphate, 5 cycles
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals have signed up for participation in this experiment?
"Affirmative. The corroborating evidence on clinicaltrials.gov states that this research is actively recruiting subjects, having posted the study in February 2019 and updated it most recently on August 10th 2022. As of now, there are still 10 spots for participants at a single medical location."
Is enrollment open for this research trial?
"This trial, with its inception on February 11th 2019 and most recent update August 10th 2022, is still recruiting candidates as reported by clinicialtrials.gov."
Could you elaborate on the research conducted concerning Fludarabine Phosphate?
"At present, 369 trials researching Fludarabine Phosphate are under operation with 22 of these studies taking place in Phase 3. Numerous clinical sites are conducting this research throughout the world, particularly so in Boston; however, there is a total of 3764 locations running tests for Fludarabine Phosphate."
Share this study with friends
Copy Link
Messenger